We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+5.72%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$20.5B
AUM Growth
+$1.25B
(+6.5%)
Cap. Flow
+$361M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
1,000
New
89
Increased
345
Reduced
485
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$309M |
| 2 |
Stellantis
STLA
|
+$198M |
| 3 |
Mastercard
MA
|
+$54.7M |
| 4 |
Truist Financial
TFC
|
+$47.4M |
| 5 |
Walt Disney
DIS
|
+$41.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$55.7M |
| 2 |
Skyworks Solutions
SWKS
|
+$47.7M |
| 3 |
RTX Corp
RTX
|
+$38.8M |
| 4 |
Adobe
ADBE
|
+$35.9M |
| 5 |
Intercontinental Exchange
ICE
|
+$32.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.63% |
| 2 | Financials | 14.68% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Healthcare | 12.77% |
| 5 | Communication Services | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Bio-Techne
TECH
$11.2B
| $1.23M | 0.01% |
12,884
-7,828
| -38% | -$714K |
|
|
NATI
802
DELISTED
National Instruments Corp
NATI
| $1.23M | 0.01% |
28,482
-7,667
| -21% | -$337K |
|
|
ALLK
803
DELISTED
Allakos
ALLK
| $1.23M | 0.01% |
10,699
-5,208
| -33% | -$658K |
|
804
Franklin Electric
FELE
$4.66B
| $1.23M | 0.01% |
+15,562
| New | +$1.17M |
|
805
Madrigal Pharmaceuticals
MDGL
$12.6B
| $1.23M | 0.01% |
10,495
+355
| +4% | +$41.4K |
|
806
Enanta Pharmaceuticals
ENTA
$362M
| $1.23M | 0.01% |
24,885
-3,392
| -12% | -$169K |
|
807
Maximus
MMS
$3.32B
| $1.23M | 0.01% |
13,779
-4,578
| -25% | -$374K |
|
808
Penumbra
PEN
$12.6B
| $1.23M | 0.01% |
4,534
-1,631
| -26% | -$421K |
|
809
Graco
GGG
$13.2B
| $1.23M | 0.01% |
17,119
-19,567
| -53% | -$1.39M |
|
810
Repligen
RGEN
$6.91B
| $1.23M | 0.01% |
6,307
-2,440
| -28% | -$500K |
|
|
NARI
811
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.23M | 0.01% |
+11,457
| New | +$1.19M |
|
812
AppFolio
APPF
$6.62B
| $1.23M | 0.01% |
8,660
-176
| -2% | -$27.3K |
|
813
John B. Sanfilippo & Son
JBSS
$986M
| $1.23M | 0.01% |
13,551
-3,431
| -20% | -$297K |
|
814
Simpson Manufacturing
SSD
$7.79B
| $1.23M | 0.01% |
11,806
-1,459
| -11% | -$146K |
|
815
Nordson
NDSN
$16.4B
| $1.22M | 0.01% |
6,162
-801
| -12% | -$156K |
|
816
Vicor
VICR
$8.33B
| $1.22M | 0.01% |
14,391
-1,830
| -11% | -$172K |
|
|
NGM
817
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.22M | 0.01% |
+42,095
| New | +$1.18M |
|
|
BKI
818
DELISTED
Black Knight, Inc. Common Stock
BKI
| $1.22M | 0.01% |
16,540
+1,731
| +12% | +$139K |
|
|
XLRN
819
DELISTED
Acceleron Pharma
XLRN
| $1.22M | 0.01% |
9,029
-2,484
| -22% | -$321K |
|
820
Commault Systems
CVLT
$4.98B
| $1.22M | 0.01% |
+18,965
| New | +$1.21M |
|
821
Globus Medical
GMED
$11.1B
| $1.22M | 0.01% |
19,827
-5,227
| -21% | -$331K |
|
|
BPMC
822
DELISTED
Blueprint Medicines
BPMC
| $1.22M | 0.01% |
+12,566
| New | +$1.25M |
|
823
CarGurus
CARG
$3.34B
| $1.22M | 0.01% |
51,272
-2,028
| -4% | -$58.8K |
|
|
CSW
824
CSW Industrials
CSW
$4.44B
| $1.22M | 0.01% |
9,049
-7,818
| -46% | -$992K |
|
825
Dolby
DLB
$4.97B
| $1.22M | 0.01% |
12,383
-6,729
| -35% | -$643K |
|
Similar funds
QCM
NAMI
Aviva's Q1 2021 Portfolio in Review
As of Q1 2021, Aviva held 1,000 positions worth $20.5B, up 6.5% from $19.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Aviva's Q1 2021 filing shows 89 new, 345 increased, 485 reduced and 62 closed positions. Its largest new stake was Ferguson: 2,534,285 shares worth $302M. The largest sale was Apple, an estimated $55.7M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- Aviva's largest Q1 2021 buy was Ferguson: 2,534,285 shares worth $302M.
- Aviva added most to Stellantis in Q1 2021, an estimated $198M increase.
- Aviva's biggest Q1 2021 reduction was Apple, cutting an estimated $55.7M.
- Aviva fully exited Tiffany & Co. in Q1 2021, selling an estimated $7.08M.
- Aviva's ten largest holdings make up 23% of its $20.5B portfolio in Q1 2021.
- Aviva opened 89 new positions and closed 62 in Q1 2021.
- Aviva's portfolio value rose 6.5% quarter-over-quarter to $20.5B.
Based on Aviva's 13F filing for Q1 2021, filed 13 May 2021.